Phase II evaluation of bisantrene in refractory multiple myeloma - A Southwest Oncology Group study

Brian G.M. Durie, John Crowley, Charles A. Coltman, Robert A. Chapman, Stanley P. Balcerzk, John D. Bonnet, David A. Lipschitz, Ronald L. Stephens, Bruce D. Cheson

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)329-331
Number of pages3
JournalInvestigational New Drugs
Issue number4
StatePublished - Nov 1991
Externally publishedYes


  • bisantrene
  • myeloma

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this